A detailed history of Atlas Brown,Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Atlas Brown,Inc. holds 71,750 shares of PFE stock, worth $2.09 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
71,750
Previous 70,182 2.23%
Holding current value
$2.09 Million
Previous $1.95 Million 3.08%
% of portfolio
0.73%
Previous 0.72%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $39,607 - $46,412
1,568 Added 2.23%
71,750 $2.01 Million
Q1 2024

Apr 08, 2024

BUY
$25.89 - $29.73 $83,780 - $96,206
3,236 Added 4.83%
70,182 $1.95 Million
Q4 2023

Jan 18, 2024

SELL
$26.13 - $33.94 $101,985 - $132,467
-3,903 Reduced 5.51%
66,946 $1.93 Million
Q3 2023

Oct 17, 2023

BUY
$32.09 - $37.51 $28,078 - $32,821
875 Added 1.25%
70,849 $2.35 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $32,038 - $37,067
887 Added 1.28%
69,974 $2.57 Million
Q1 2023

Apr 21, 2023

BUY
$39.39 - $51.28 $105,722 - $137,635
2,684 Added 4.04%
69,087 $2.82 Million
Q4 2022

Jan 05, 2023

SELL
$41.75 - $54.5 $185,912 - $242,688
-4,453 Reduced 6.28%
66,403 $0
Q3 2022

Oct 06, 2022

BUY
$43.76 - $53.42 $39,427 - $48,131
901 Added 1.29%
70,856 $3.1 Million
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $20,612 - $24,440
443 Added 0.64%
69,955 $3.67 Million
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $174,765 - $216,555
3,820 Added 5.82%
69,512 $3.6 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $23,015 - $34,116
-557 Reduced 0.84%
65,692 $3.88 Million
Q3 2021

Oct 14, 2021

BUY
$39.25 - $50.42 $31,203 - $40,083
795 Added 1.21%
66,249 $2.85 Million
Q2 2021

Jul 19, 2021

BUY
$35.91 - $40.68 $192,513 - $218,085
5,361 Added 8.92%
65,454 $2.56 Million
Q1 2021

Apr 13, 2021

BUY
$33.49 - $37.77 $179,841 - $202,824
5,370 Added 9.81%
60,093 $2.18 Million
Q4 2020

Jan 19, 2021

BUY
$33.47 - $42.56 $56,162 - $71,415
1,678 Added 3.16%
54,723 $2.01 Million
Q3 2020

Oct 15, 2020

BUY
$31.75 - $37.25 $18,542 - $21,754
584 Added 1.11%
53,045 $1.95 Million
Q2 2020

Jul 21, 2020

SELL
$30.12 - $36.54 $4,367 - $5,298
-145 Reduced 0.28%
52,461 $1.72 Million
Q1 2020

Apr 16, 2020

BUY
$27.03 - $38.62 $79,333 - $113,349
2,935 Added 5.91%
52,606 $1.72 Million
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $110,084 - $124,931
3,344 Added 7.22%
49,671 $1.95 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $52,081 - $67,534
-1,603 Reduced 3.34%
46,327 $1.67 Million
Q2 2019

Jul 24, 2019

BUY
$36.98 - $41.52 $14,126 - $15,860
382 Added 0.8%
47,930 $2.08 Million
Q1 2019

Apr 12, 2019

SELL
$37.5 - $41.2 $70,200 - $77,126
-1,872 Reduced 3.79%
47,548 $2.02 Million
Q4 2018

Jan 28, 2019

BUY
$38.47 - $43.86 $47,318 - $53,947
1,230 Added 2.55%
49,420 $2.16 Million
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $127,711 - $154,906
-3,705 Reduced 7.14%
48,190 $2.12 Million
Q2 2018

Jul 11, 2018

BUY
$32.98 - $35.16 $5,309 - $5,660
161 Added 0.31%
51,895 $1.94 Million
Q1 2018

Apr 17, 2018

BUY
$31.91 - $37.02 $75,754 - $87,885
2,374 Added 4.81%
51,734 $1.84 Million
Q4 2017

Jan 25, 2018

BUY
$33.26 - $35.29 $24,945 - $26,467
750 Added 1.54%
49,360 $1.82 Million
Q3 2017

Oct 12, 2017

BUY
$31.0 - $34.15 $1.51 Million - $1.66 Million
48,610
48,610 $1.74 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Atlas Brown,Inc. Portfolio

Follow Atlas Brown,Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.